Effect of thyrotropin releasing hormone (TRH) on gene expressions in rat pancreas: Approach by microarray hybridization

Journal of the Pancreas

Volumn 5, Issue 4, 2004, Pages 193-204

  Yano, Naohiro ^a   Luo, Lu Guang ^a  

^a RHODE ISLAND HOSPITAL   (United States)

Author keywords

Apoptosis; Growth substances; Oligonucleotide array sequence analysis; Pancreas; Receptors, thyrotropin releasing hormone

Indexed keywords

AMYLASE; BETA ARRESTIN; ENDOTHELIN 1; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; INSULIN; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR B; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTIRELIN; SOMATOMEDIN B; SOMATOMEDIN C; RNA; TISSUE EXTRACT;

AMYLASE RELEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; MALE; NONHUMAN; NORTHERN BLOTTING; RAT; RNA ISOLATION; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DOWN REGULATION; DRUG EFFECT; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; ORGAN SIZE; PANCREAS; PHYSIOLOGY; SPRAGUE DAWLEY RAT; UPREGULATION;

ANIMALS; BLOTTING, NORTHERN; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENES; INSULIN; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; RESEARCH DESIGN; RNA; THYROTROPIN-RELEASING HORMONE; TISSUE EXTRACTS; UP-REGULATION;

EID: 6344252881     PISSN: 15908577     EISSN: 15908577     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Boler J, Enzmann F, Folkers K, Bowers CY, Schally AV. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun 1969; 37:705-10.
2. Burgus R, Dunn TF, Desiderio D, Guillemin R. Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro-HH2 sequence. CR Acad Sci Hebd Seances Acad Sci D 1969; 269:1870-3
3. Hajjar RA, Anderson MS, Samaan NA. Thyrotropin-releasing hormone as a pituitary-function indicator. A comparison with other tests. Arch Intern Med 1973; 132:836-9.
4. Azizi F, Vagenakis AG, Bollinger J, Reichlin S, Bush JE, Braverman LE. The effect of a single large dose of thyrotropin-releasing hormone on various aspects of thyroid function in the rat. Endocrinology 1974; 95:1767-70.
5. Jackson IM, Reichlin S. Thyrotropin releasing hormine (TRH): distribution in the brain, blood and urine of the rat. Life Sci 1974; 14:2259-66.
6. Jackson IM, Reichlin S. Thyrotropin-releasing hormone (TRH): distribution in hypothalamic and extrahypothalamic brain tissues of mammalian and submammalian chordates. Endocrinology 1974; 95:854-62.
7. Martino E, Lernmark A, Seo H, Steiner DF, Refetoff S. High concentration of thyrotropin-releasing hormone in pancreatic islets. Proc Natl Acad Sci USA 1978; 75:4265-7.
8. Amir S, Butler PD. Thyrotropin-releasing hormone blocks neurally-mediated hyperglycemia through central action. Peptides 1988; 9:31-5.
9. Amir S, Harel M, Rivkind AI. Thyrotropin-releasing hormone potently reverses epinephrine-stimulated hyperglycemia in mice. Brain Res 1987; 435:112-22.
10. Amir S. Thyrotropin-releasing hormone (TRH) blocks glucagon-induced hyperglycemia in mice: dissociation of the antihyperglycemic and pituitary actions of TRH. Brain Res 1988; 455:201-3.
11. Amir S, Rivkind AI. Prevention of clonidine-stimulated hyperglycemia by thyrotropin-releasing hormone. Peptides 1988; 9:527-31.
12. Amir S, Rivkind AI, Harel M. Central thyrotropin-releasing hormone elicits systemic hypoglycemia in mice. Brain Res 1985; 344:387-91.
13. Amir S, Jackson IM. Immunological blockade of endogenous thyrotropin-releasing hormone impairs recovery from hyperglycemia in mice. Brain Res 1988; 462:160-2.
14. Masuda M, Kanai S, Miyasaka K. Central somatostatin prevents vagal efferent nerve excitation produced by TRH but not by 2-deoxy-D-glucose. Am J Physiol 1997; 272:G351-6.
15. Dutour A, Giraud P. Kowalski C, Ouafik L, Salers P, Strbak V, Oliver C. Ontogenesis of TRH mRNA in the rat pancreas. Biochem Biophys Res Commun 1987; 146:354-60.
16. Blanco-Molina A, Lopez-Miranda J, Nicolas-Puiggari M, Torre-Cisneros J, Lopez-Segura F, Perez-Jimenez F. Evidence of a direct TRH effect on the exocrine pancreas. Rev Esp Fisiol 1991; 47:173-9.
17. Ebiou JC, Grouselle D, Aratan-Spire S. Antithyrotropin-releasing hormone serum inhibits secretion of glucagon from isolated perfused rat pancreas: an experimental model for positive feedback regulation of glucagon secretion. Endocrinology 1992; 131:765-71. Antithyrotropin-releasing hormone serum inhibits secretion of glucagon from isolated perfused rat pancreas: an experimental model for positive feedback regulation of glucagon secretion. Endocrinology 1992; 131:765-71.
18. Kulkarni RN, Wang ZL, Akinsanya KO, Bennet WM, Wang RM, Smith DM, et al. Pyroglutamyl-phenylalanyl-proline amide attenuates thyrotropin-releasing hormone-stimulated insulin secretion in perifused rat islets and insulin-secreting clonal beta-cell lines. Endocrinology 1995; 136:5155-64.
19. Schuit F, Flamez D, De Vos A, Pipeleers, D. Glucose-regulated gene expression maintaining the glucose-responsive state of beta-cells. Diabetes 2002; 51:S326-32.
20. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with complementary DNA microarray. Science 1995; 270:467-70.
21. Schena M, Shalon, D, Heller R, Chai A, Brown, PO. Parallel human genome analysis: Microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 1996; 93:10614-9.
22. Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta or gamma using oligonucleotide arrays. Proc Natl Acad Sci USA 1998; 95:15623-8.
23. Yano N, Endoh M, Fadden K, Yamashita H, Kane A, Sakai H, Rifai R. Comprehensive gene expression profile of the adult human renal cortex: analysis by cDNA array hybridization. Kidney Int 2000; 57:1452-9.
24. Yano N, Endoh M, Fadden K, Yamashita H, Sakai H, Kurokawa K, Abboud HE, et al. Genomic repertoire of human mesangial cells: comprehensive analysis of gene expression by cDNA array hybridization. Nephrology 2000; 5:215-23.
25. Yano N, Habib NA, Fadden KJ, Yamashita H, Mitry R, Jauregui H, et al. Profiling the adult human liver transcriptome: analysis by cDNA array hybridization. J Hepatol 2001; 35:178-86.
26. Hegde P, Qi R, Abernathy K, Gay C, Dharap S, Gaspard R, et al. A concise guide to cDNA microarray analysis. Biotechniques 2000; 29:548-56.
27. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292:1389-94.
28. Wolff G, Mastrangeli A, Heinflink M, Falck-Pedersen E, Gershengorn MC, Crystal RG. Ectopic expression of thyrotropin releasing hormone (TRH) receptors in liver modulates organ function to regulate blood glucose by TRH. Nat Genet 1996; 12:274-9.
29. Emanuel RL, Torday JS, Asokananthan N, Sunday ME. Direct effects of corticotropin-releasing hormone and thyrotropin-releasing hormone on fetal lung explants. Peptides 2000; 21:1819-29.
30. Morley JE. Extrahypothalamic thyrotropin releasing hormone (TRH) - its distribution and its functions. Life Sci 1979; 25:1539-50.
31. Engler D, Chad D, Jackson IM. Thyrotropin-releasing hormone in the pancreas and brain of the rat is regulated by central noradrenergic and dopaminergic pathways. J Clin Invest 1982; 69:1310-20.
32. Aratan-Spire S, Wolf B, Czernichow P. Developmental pattern of TRH-degrading activity and TRH content in rat pancreas. Acta Endocrinol (Copenh) 1984; 106:102-8.
33. Glasbrenner B, Malfertheiner P, Duntas L, Buchler M, Bereiter T, Ditschuneit H. Effects of TRH on pancreatic growth and secretion in rats. Pancreas 1990; 5:37-41.
34. Luttrell LM, Lefkowitz RJ. The role of beta-arrestin in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 2002; 115:455-65.
35. Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999; 283:655-61.
36. Imamura, T, Huang J, Dalle S, Ugi S, Usui I, Luttrell LM, Miller WE, et al. Beta -arrestin-mediated recruitment of the Src family kinase Yes mediates endothelin-1-stimulated glucose transport. J Biol Chem 2001; 276:43663-7.
37. Penela P, Elorza A, Sarnago S, Mayor F Jr. Beta-arrestin- and c-Src-dependent degradation of G-protein-coupled receptor kinase 2. EMBO J 2001; 20:5129-38.
38. Luo LG, Yano N, Zhu YH, Smith RJ. Activation of EGF receptors in pancreatic beta cells by thyrotropin releasing hormone (TRH): Cross-talk between neuropeptide and growth factor receptors (Abstract). Diabetes 2002; 51(Suppl 1):A1629.
39. Rhodes CJ. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J Mol Endocrinol 2000; 24:303-11.
40. Sykes JE, Lowry PJ. Purification of a high-molecular-weight-somatoliberin (growth hormone-releasing factor) from pig hypothalami. Biochem J 1983; 209:643-51.
41. Basavappa S, Mangel AW, Scott L, Liddle RA. Activation of calcium channels by cAMP in STC-1 cells is dependent upon Ca2+ calmodulin-dependent protein kinase II. Biochem Biophys Res Commun 1999; 254:699-702.
42. Takasawa S, Ishida A, Nata K, Nakagawa K, Noguchi N, Tohgo A, et al. Requirement of calmodulin-dependent protein kinase II in cyclic ADP-ribose-mediated intracellular Ca2+ mobilization. J Biol Chem 1995; 270:30257-9.
43. Kiraly-Borri CE, Morgan A, Burgoyne RD, Weller U, Wollheim CB, Lang J. Soluble N-ethylmaleimide-sensitive-factor attachment protein and N-ethylmaleimide-insensitive factors are required for Ca2+-stimulated exocytosis of insulin. Biochem J 1996; 314:199-203.
44. Mohlig M, Wolter S, Mayer P, Lang J, Osterhoff M, Horn PA, et al. Insulinoma cells contain an isoform of Ca2+ / calmodulin-dependent protein kinase II delta associated with insulin secretion vesicles. Endocrinology 1997; 138:2577-84.
45. Bertrand G, Gross R, Puech R, Loubatieres-Mariani MM, Bockaert J. Evidence for a glutamate receptor of the AMPA subtype which mediates insulin release from rat perfused pancreas. Br J Pharmacol 1992; 106:354-9.
46. Todd JF, Wilding JP, Edwards CM, Khan FA, Ghatei MA, Bloom SR. Glucagon-like peptide-I (GLP-1) - a trial of treatment in noninsulin-dependent diabetes mellitus. Eur J Clin Invest 1997; 27:533-6.
47. Zander M, Madsbad S, Madsen JL, Holst JJ. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 2002; 359:824-30.
48. Behme MT, Dupré J, McDonald TJ. Glucagon-like peptide I improved glycemic control in type I diabetes. BMC Endocr Disord 2003; 3:3.
49. Kothapalli R, Yoder SJ, Mane S, Loughran TP Jr. Microarray results: how accurate are they? BMC Bioinformatics 2002; 3:22.